Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 88651-88700 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05250037
The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)
N/ARecruiting
250 participants
Started: Mar 30, 2022 · Completed: Jun 30, 2028
2 conditions2 sponsors4 locations
NCT04985266
A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer
PHASE2Recruiting
1,100 participants
Started: Mar 30, 2022 · Completed: Sep 1, 2030
2 conditions7 sponsors49 locations
NCT05108259
To Compare the Pharmacokinetics and Safety of PBP1502 and Humira in Healthy Subjects
PHASE1Recruiting
324 participants
Started: Mar 30, 2022 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT04380740
Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis
PHASE2Active, not recruiting
160 participants
Started: Mar 30, 2022 · Completed: Jun 30, 2028
1 condition2 sponsors14 locations
NCT04990895
A Research Study to Collect Patient Reported Outcomes Using Electronic Surveys
NARecruiting
128 participants
Started: Mar 30, 2022 · Completed: Oct 1, 2026
2 conditions2 sponsors1 location
NCT05009160
DreaMS - Validation Study 1
N/ARecruiting
300 participants
Started: Mar 30, 2022 · Completed: Mar 31, 2027
1 condition7 sponsors6 locations
NCT05116904
Smith Magenis Syndrome and Autism Spectrum Disorders
NARecruiting
40 participants
Started: Mar 30, 2022 · Completed: Apr 30, 2026
2 conditions1 sponsor2 locations
NCT05320627
Population Pharmacokinetics of Edoxaban in Chinese Patients With Non-Valvular Atrial Fibrillation
PHASE4Recruiting
120 participants
Started: Mar 30, 2022 · Completed: Dec 30, 2024
1 condition2 sponsors1 location
NCT05199857
WE BEAT - HEART Club Fontan Wellness Project: A Virtual Resilience Promotion and Frailty Prevention Program
NARecruiting
30 participants
Started: Mar 30, 2022 · Completed: Jul 31, 2026
3 conditions2 sponsors1 location
NCT05145647
To Observe the Benefit of Adding Brachytherapy After CCRT on Resectable Esophageal Cancer Patients Without Surgery
NARecruiting
18 participants
Started: Mar 30, 2022 · Completed: Jun 18, 2025
1 condition1 sponsor1 location
NCT05410977
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
N/ARecruiting
750 participants
Started: Mar 30, 2022 · Completed: Apr 1, 2027
2 conditions2 sponsors9 locations
NCT05224414
Interpretation Bias as a Mechanism of Treatment Response in OCD
NARecruiting
106 participants
Started: Mar 30, 2022 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT05186948
Development and Validation of a Novel Functional Eye-Tracking Software Application for Cancer-related Cognitive Impairment (CRCI)
N/ARecruiting
230 participants
Started: Mar 30, 2022 · Completed: Jan 20, 2025
1 condition1 sponsor1 location
NCT06353035
Biodiversity Interventions for Well-Being
NAActive, not recruiting
30 participants
Started: Mar 30, 2022 · Completed: Sep 30, 2027
4 conditions2 sponsors1 location
NCT05112445
"Retinal Ischemia Characterization in Diabetes - RICHARD"
N/AActive, not recruiting
60 participants
Started: Mar 30, 2022 · Completed: Oct 31, 2025
1 condition2 sponsors1 location
NCT05248230
4D-710 in Adult Patients With Cystic Fibrosis
PHASE1/PHASE2Recruiting
40 participants
Started: Mar 29, 2022 · Completed: Jan 31, 2030
1 condition1 sponsor19 locations
NCT06654648
Combined Exercise and Nutrition Intervention for Sarcopenia
NARecruiting
118 participants
Started: Mar 29, 2022 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT05201859
Adjuvant Sintilimab Plus Capecitabine in Nasopharyngeal Carcinoma
PHASE2Recruiting
150 participants
Started: Mar 29, 2022 · Completed: Feb 15, 2026
1 condition1 sponsor1 location
NCT05161858
Longitudinal Characterization of Respiratory Tract Exacerbations and Treatment Responses in Primary Ciliary Dyskinesia
N/AActive, not recruiting
105 participants
Started: Mar 29, 2022 · Completed: Sep 30, 2025
2 conditions8 sponsors7 locations
NCT05264298
Video-based Intervention to Address Disparities in Blood Pressure Control After Stroke
NAActive, not recruiting
542 participants
Started: Mar 29, 2022 · Completed: Jun 29, 2026
1 condition2 sponsors1 location
NCT05336695
Assess Fibrin in Brains With AD/ADRD
PHASE1/PHASE2Recruiting
30 participants
Started: Mar 29, 2022 · Completed: Sep 28, 2026
2 conditions2 sponsors1 location
NCT04800393
The Impact of Inhalation vs Total Intravenous Anesthesia on the Immune Status and Mortality in Patients Undergoing Breast Cancer Surgery: a Prospective Double-Blind Randomized Clinical Trial.
NARecruiting
130 participants
Started: Mar 29, 2022 · Completed: Apr 1, 2028
2 conditions2 sponsors1 location
NCT05030038
Oral Aromatase Inhibitors Modify the Gut Microbiome
N/ARecruiting
25 participants
Started: Mar 29, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05387304
A Follow-up Study of Asymptomatic Infections and Diagnosed Patients With Covid-19 in Shanghai
N/ARecruiting
250,000 participants
Started: Mar 29, 2022 · Completed: May 31, 2032
1 condition1 sponsor1 location
NCT05022134
Evaluating the Impact of CHOICE-AYA on Contraceptive Use, Continuation and Satisfaction
NAEnrolling by invitation
200 participants
Started: Mar 29, 2022 · Completed: Aug 30, 2027
3 conditions1 sponsor1 location
NCT05232929
Long-term Follow-up Study of Risdiplam in Participants With Spinal Muscular Atrophy (SMA)
PHASE4Active, not recruiting
402 participants
Started: Mar 29, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor39 locations
NCT05247255
Quadratus Lumborum Block for Total Hip Arthroplasty
EARLY_PHASE1Recruiting
80 participants
Started: Mar 29, 2022 · Completed: Jan 31, 2027
1 condition1 sponsor1 location
NCT05505669
Circulating Biomarkers in the Development of Type 1 Diabetes
N/ARecruiting
165 participants
Started: Mar 29, 2022 · Completed: Dec 21, 2025
1 condition3 sponsors1 location
NCT05154331
Antenatal and Postnatal Care Research Collective - Household Survey (ARCH)
N/ARecruiting
7,500 participants
Started: Mar 29, 2022 · Completed: Jun 1, 2026
2 conditions3 sponsors1 location
NCT05368467
National Registry and Cohort Study of Pulmonary Vascular Disease
N/ARecruiting
1,000 participants
Started: Mar 29, 2022 · Completed: Dec 30, 2028
1 condition1 sponsor13 locations
NCT05065957
Study of Combination Therapy of D07001-Softgel Capsules and Xeloda/TS-1 in Subjects With Advanced Biliary Tract Cancer
PHASE2/PHASE3Recruiting
180 participants
Started: Mar 29, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor5 locations
NCT05270668
Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007)
PHASE2Active, not recruiting
154 participants
Started: Mar 29, 2022 · Completed: Jul 31, 2029
2 conditions1 sponsor95 locations
NCT05241093
A Study of HYML-122 and Cytarabine in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)
PHASE2Recruiting
18 participants
Started: Mar 29, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05348915
A Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants With Sickle Cell Disease
PHASE3Active, not recruiting
147 participants
Started: Mar 29, 2022 · Completed: Nov 4, 2028
3 conditions1 sponsor49 locations
NCT05479669
Value of Intense Phenotyping in Heart Failure With Preserved Ejection Fraction
N/ARecruiting
200 participants
Started: Mar 29, 2022 · Completed: Jan 1, 2031
1 condition1 sponsor1 location
NCT04963777
Prebiotics in Patients With Type 1 Diabetes
NARecruiting
144 participants
Started: Mar 29, 2022 · Completed: Sep 1, 2027
1 condition1 sponsor3 locations
NCT05163808
A Randomized Study of BPN14770 in Male Adolescents (Aged 9 to < 18 Years) With Fragile X Syndrome
PHASE2/PHASE3Active, not recruiting
163 participants
Started: Mar 29, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor17 locations
NCT04645147
Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults With or Without EBV Infection
PHASE1Active, not recruiting
83 participants
Started: Mar 29, 2022 · Completed: Jul 1, 2026
3 conditions1 sponsor1 location
NCT05196035
A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria
PHASE3Recruiting
219 participants
Started: Mar 28, 2022 · Completed: Aug 31, 2027
2 conditions1 sponsor163 locations
NCT05448326
The Diagnostic Observatory: Combating Diagnostic Wandering and Impasse Within the AnDDI-Rares Network
N/ARecruiting
1,280 participants
Started: Mar 28, 2022 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT05244304
Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Adolescent Stargardt Disease
PHASE3Active, not recruiting
104 participants
Started: Mar 28, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor19 locations
NCT05886504
Drug Use & Infections in ViEtnam: Mental Health Intervention for INjecting Drug Users
NAActive, not recruiting
567 participants
Started: Mar 28, 2022 · Completed: Jul 28, 2024
2 conditions5 sponsors1 location
NCT05326919
The Patient Cohort of the National Center for Precision Medicine in Leukemia
N/ARecruiting
3,000 participants
Started: Mar 28, 2022 · Completed: Mar 31, 2042
5 conditions1 sponsor3 locations
NCT05167201
Domiciliary Nasal High Flow and Patient Outcomes in Chronic Hypercapnic Respiratory Failure in the United Kingdom
NAActive, not recruiting
54 participants
Started: Mar 28, 2022 · Completed: Jan 26, 2024
5 conditions3 sponsors1 location
NCT05204212
Left Atrial Appendage Closure in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic KIDNEY Disease
NARecruiting
430 participants
Started: Mar 28, 2022 · Completed: Jan 14, 2028
1 condition1 sponsor1 location
NCT05345106
Inter-relationships Among Glucose, Brain, Gut Microbiota and MicroRNAs (IRONmiRNA).
N/ARecruiting
120 participants
Started: Mar 28, 2022 · Completed: Dec 12, 2024
1 condition1 sponsor1 location
NCT05182710
Simulation-based Stress Inoculation Training Study for UK Medical Professionals
NAEnrolling by invitation
40 participants
Started: Mar 28, 2022 · Completed: Aug 30, 2024
3 conditions1 sponsor1 location
NCT05252208
Stretching vs Walking for Lowering Blood Pressure
NARecruiting
96 participants
Started: Mar 28, 2022 · Completed: Aug 30, 2026
1 condition2 sponsors1 location
NCT05289856
Cabozantinib in Combination With Avelumab in Patients Refractory to Standard Chemotherapy With Advanced Neuroendocrine Neoplasias G3 (NEN G3)
PHASE2Active, not recruiting
30 participants
Started: Mar 28, 2022 · Completed: Dec 1, 2025
1 condition3 sponsors2 locations
NCT05207709
Ribociclib vs. Palbociclib in Patients With Advanced Breast Cancer Within the HER2-Enriched Intrinsic Subtype
PHASE3Active, not recruiting
456 participants
Started: Mar 28, 2022 · Completed: Mar 1, 2027
1 condition3 sponsors71 locations